怪物飲料 MNST 深 滬
已收盤 11-06 16:00:00 美东时间
45.72
-2.110
-4.41%
華盛通- 最 高46.84
- 今 開44.04
- 成交量 1568.19万股
- 最 低 43.9329
- 昨 收 47.83
- 總市值 895.68亿
- 52周最高 50.17
- 市盈率 靜 47.24
- 換手率 0.80%
- 52周最低 35.43
- 委 比 -75.45%
- 總股本 19.59亿
- 歷史最高 50.17
- 量 比 1.24
- 振 幅 6.08%
- 歷史最低 2.8692
- 每 手 1
- 風險率 4.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多魔爪饮料单季卖出172亿元！国际业务占比升至47%，中国市场销售额大增43.8%领跑
作者丨焦逸梦编审丨橘子 北京时间11月6日早上，依托重要战略股东可口可乐装瓶渠道在华快速发展的能量饮料品牌“魔爪”（母公司Monster Beve...
11-07 10:49
PowerShares Dynamic Consumer Sta前十大重仓股占比35.2143%，第一大重仓股为Casey’
数据显示，PowerShares Dynamic Consumer Sta前十大重仓股合计占基金资产的35.2143%。 其中，第一大重仓股为Casey’，持仓...
11-07 07:14
Wall Street Analysts Are Bullish on Top Consumer Goods Picks
There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts...
11-06 21:50
财报速睇 | 怪物饮料 2026财年Q3营收25.63亿美元，同比增长16.7%；归母净利润5.68亿美元，同比增长8.4%
华盛资讯11月6日讯，怪物饮料公布2026财年Q3业绩，公司Q3营收25.63亿美元，同比增长16.7%，归母净利润5.68亿美元，同比增长8.4%。
11-06 19:18
美股夜盘 | Cloudflare劲升14.51%，爱彼迎劲升10.82%
奥洛兹美医疗大跌6.96%；Affirm大跌6.70%；Axon Enterprise大跌6.38%
11-06 09:06
财报速睇 | 怪物饮料 2026财年Q3营收25.63亿美元，同比增长16.7%；归母净利润5.68亿美元，同比增长8.4%
华盛资讯11月6日讯，怪物饮料公布2026财年Q3业绩，公司Q3营收25.63亿美元，同比增长16.7%，归母净利润5.68亿美元，同比增长8.4%。
11-06 06:23
Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test
Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and Canadian Natural Resources report before the open, while Airbnb, Cloudflare, Monster Beverage, EOG Re...
11-05 04:31
$100 Invested In Monster Beverage 5 Years Ago Would Be Worth This Much Today
Monster Beverage (NASDAQ:MNST) has outperformed the market over the past 5 years by 5.38% on an annualized basis producing an average annual return of 15.81%. Currently, Monster Beverage has a market capitalization of $92.43 billion. Buying $100 In MNST: If an investor had bought $100 of MNST stock ...
11-04 23:01
怪物饮料收涨1.44%，成交额4.94亿美元
11月3日，怪物饮料（MNST）收涨1.44%，报48.02美元，成交额4.94亿美元，市值940.74亿美元。 行情数据 • 开盘价：47.79美元 • 最高...
11-03 05:34
Jim Cramer Calls Celsius 'A Second-Rate Monster,' Says Stick With the Original
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said ImmunityBio, Inc. (NASDAQ:IBRX) is a “very good spec.” ImmunityBio, on Oct. 14, announced that the FDA expanded the approved indication for its bladder cancer immunotherapy ANKTIVA to include BCG-unresponsive non-muscle-invasive bladder cancer w...
10-27 20:31
